Guardant Health, Inc. (GH) Earnings
Guardant Health, Inc.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Jul 30, 2026
From the latest earnings 8-K
Revenue • FY2025
$982.02M
▲ 32.9%YoY
Diluted EPS • FY2025
$-3.32
▲ 6.7%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from GH's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $982.02M | -$416.28M | $633.01M | $-3.32 | -$233.07M | -44.5% | +32.9% |
| FY2024 | $739.02M | -$436.37M | — | $-3.56 | -$274.94M | -60.0% | +31.0% |
| FY2023 | $563.95M | -$479.45M | — | $-4.28 | -$345.46M | -100.1% | +25.4% |
| FY2022 | $449.54M | -$654.59M | — | $-6.41 | -$386.92M | -121.1% | +20.3% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Jul 30, 2026 | 8-K (2.02) | 0001576280-26-000036EDGAR |
| May 7, 2026 | 8-K (2.02) | 0001576280-26-000024EDGAR |
| Feb 19, 2026 | 8-K (2.02) | 0001576280-26-000012EDGAR |
| Jan 12, 2026 | 8-K (2.02) | 0001576280-26-000004EDGAR |
| Oct 29, 2025 | 8-K (2.02) | 0001576280-25-000276EDGAR |
| Jul 30, 2025 | 8-K (2.02) | 0001576280-25-000245EDGAR |
| Apr 30, 2025 | 8-K (2.02) | 0001576280-25-000135EDGAR |
| Feb 20, 2025 | 8-K (2.02) | 0001576280-25-000043EDGAR |
Never miss a GH filing.
Get an email when GH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 16, 2026Source: SEC EDGAR.